The dimer interface of the membrane type 1 matrix metalloproteinase hemopexin domain: crystal structure and biological functions.

The dimer interface of the membrane type 1 matrix metalloproteinase hemopexin domain: crystal structure and biological functions.

Homodimerization is an essential step for membrane type 1 matrix metalloproteinase (MT1-MMP) to activate proMMP-2 and to degrade collagen on the cell surface. To uncover the molecular basis of the hemopexin (Hpx) domain-driven dimerization of MT1-MMP, a crystal structure of the Hpx domain was solved...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Tochowicz, A, Goettig, P, Evans, R, Visse, R, Shitomi, Y, Palmisano, R, Ito, N, Richter, K, Maskos, K, Franke, D, Svergun, D, Nagase, H, Bode, W, Itoh, Y
Format:	Journal article
Sprache:	English
Veröffentlicht:	2011

Ähnliche Einträge

Crystal structure of MT1-MMP hemopexin domain: identification of the dimer interface
von: Tochowicz, A, et al.
Veröffentlicht: (2010)

Distinct roles of the hemopexin and the transmembrane domains as dimer interfaces of MT1-MMP on the cell surface
von: Itoh, Y, et al.
Veröffentlicht: (2007)

Triple-helical collagen unwinding relies on cooperative binding of the catalytic and hemopexin domains of collagenase
von: Manka, S, et al.
Veröffentlicht: (2010)

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
von: Visse, R, et al.
Veröffentlicht: (2003)

CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase.
von: Suenaga, N, et al.
Veröffentlicht: (2005)

Ectodomain shedding of discoidin domain receptor 1 (DDR1) by a metalloproteinase
von: Shitomi, Y, et al.
Veröffentlicht: (2011)

CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain.
von: Mori, H, et al.
Veröffentlicht: (2002)

Structure and function of matrix metalloproteinases and TIMPs.
von: Nagase, H, et al.
Veröffentlicht: (2006)

Matrix metalloproteinases in cancer.
von: Itoh, Y, et al.
Veröffentlicht: (2002)

Discoidin domain receptor 2 mediates collagen-induced activation of membrane-type 1 matrix metalloproteinase in human fibroblasts
von: Majkowska, I, et al.
Veröffentlicht: (2017)

CD44 directs membrane-type 1 matrix metalloproteinase (MT1-MMP) to lamellipodia by associating with its hemopexin-like domain (PEX)
von: Mori, H, et al.
Veröffentlicht: (2002)

X-ray structure of human proMMP-1: new insights into procollagenase activation and collagen binding.
von: Jozic, D, et al.
Veröffentlicht: (2005)

Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface.
von: Itoh, Y, et al.
Veröffentlicht: (1998)

MT-LOOP-dependent localization of membrane type I matrix metalloproteinase (MT1-MMP) to the cell adhesion complexes promotes cancer cell invasion.
von: Woskowicz, A, et al.
Veröffentlicht: (2013)

Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase.
von: Itoh, Y, et al.
Veröffentlicht: (1995)

Dimerization of MT1-MMP during cellular invasion detected by fluorescence resonance energy transfer.
von: Itoh, Y, et al.
Veröffentlicht: (2011)

Skeletal muscle atrophy‐induced hemopexin accelerates onset of cognitive impairment in Alzheimer's disease
von: Tsukasa Nagase, et al.
Veröffentlicht: (2021-12-01)

Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases.
von: Ogata, Y, et al.
Veröffentlicht: (1995)

The second dimer interface of MT1-MMP, the transmembrane domain, is essential for ProMMP-2 activation on the cell surface.
von: Itoh, Y, et al.
Veröffentlicht: (2008)

Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.
von: Itoh, Y, et al.
Veröffentlicht: (1995)

Engineered tissue inhibitor of metalloproteinases-3 variants resistant to endocytosis have prolonged chondroprotective activity
von: Doherty, C, et al.
Veröffentlicht: (2016)

Degradation of interleukin 1beta by matrix metalloproteinases.
von: Ito, A, et al.
Veröffentlicht: (1996)

Homophilic complex formation of MT1-matrix metalloproteinase is essential to express collagenolytic activity on the cell surface
von: Itoh, Y, et al.
Veröffentlicht: (2005)

Matrix metalloproteinase 1 interacts with neuronal integrins and stimulates dephosphorylation of Akt.
von: Conant, K, et al.
Veröffentlicht: (2004)

Matrix metalloproteinases and their inhibitors in human vitreous.
von: De La Paz, MA, et al.
Veröffentlicht: (1998)

Purified and Recombinant Hemopexin: Protease Activity and Effect on Neutrophil Chemotaxis
von: Tian Lin, et al.
Veröffentlicht: (2016-01-01)

Carcinomas contain a matrix metalloproteinase-resistant isoform of type I collagen exerting selective support to invasion.
von: Makareeva, E, et al.
Veröffentlicht: (2010)

Structural insights into triple-helical collagen cleavage by matrix metalloproteinase 1.
von: Manka, S, et al.
Veröffentlicht: (2012)

Importance of matrix metalloproteinases in human trophoblast invasion.
von: Bischof, P, et al.
Veröffentlicht: (1995)

Data demonstrating the anti-oxidant role of hemopexin in the heart
von: Giada Ingoglia, et al.
Veröffentlicht: (2017-08-01)

A role for hemopexin in oligodendrocyte differentiation and myelin formation.
von: Noemi Morello, et al.
Veröffentlicht: (2011-01-01)

Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors.
von: Nagase, H, et al.
Veröffentlicht: (2003)

Collagenases and aggrecanases: understanding the role of non-catalytic domains in cartilage matrix breakdown
von: Nagase, H, et al.
Veröffentlicht: (2005)

MMP-13 is constitutively produced in human chondrocytes and co-endocytosed with ADAMTS-5 and TIMP-3 by the endocytic receptor LRP1
von: Yamamoto, K, et al.
Veröffentlicht: (2016)

Hemopexin alleviates sterile inflammation in ischemia-reperfusion-induced lung injury
von: Tomoyuki Nakagiri, et al.
Veröffentlicht: (2024-10-01)

Hemopexin Modulates Expression of Complement Regulatory Proteins in Rat Glomeruli
von: Maria G. Detsika, et al.
Veröffentlicht: (2021-09-01)

Matrix metalloproteinases and TIMPS in cultured C57BL/6J-cpk kidney tubules.
von: Rankin, C, et al.
Veröffentlicht: (1996)

The roles of substrate thermal stability and P2 and P1' subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity.
von: Minond, D, et al.
Veröffentlicht: (2006)

Metalloproteinase binding proteins: WO2009097397.
von: Itoh, Y
Veröffentlicht: (2010)

Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. In search of selective matrix metalloproteinase inhibitors.
von: Wei, S, et al.
Veröffentlicht: (2003)